Apixaban (trade name: Eliquis) is a direct factor Xa inhibitor for the treatment of venous thromboembolic events. Apixaban has been approved by the U.S Food and Drug Administration on March 18, 2014.
Product Name: Apixaban
CAS Number: 503612-47-3
Molecular Weight:  459.5
Molecular Formula:  C25H25N5O4
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.